Search research articles
Contact Us
Filters
Showing results (11-20 of 208) with videos related to
Page
of 21
Sort By:
Hematology (Amsterdam, Netherlands)
|
April 18, 2012
Allogeneic transplantation for aplastic anemia
Mary Eapen
Best Practice & Research. Clinical Haematology
|
November 21, 2017
Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant?
Mary Eapen
Blood
|
January 5, 2023
To treat with curative intent or modify disease?
Mary Eapen
Haematologica
|
July 1, 2024
Immunosuppression with post-transplant cyclophosphamide for allogeneic hematopoietic cell transplantation
Mary Eapen
The Lancet. Haematology
|
February 3, 2019
In-vivo T-cell depletion: burden of morbidity versus survival
Mary Eapen
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 11, 2010
Bone marrow or peripheral blood
Mary Eapen
Best Practice & Research. Clinical Haematology
|
December 3, 2014
Unrelated donor transplantation: peripheral blood or bone marrow--does it matter?
Mary Eapen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 12, 2023
Reply to R. Meisel
Mary Eapen, Ruta Brazaukas
Lifetime Data Analysis
|
July 9, 2008
Principles and analysis of hematopoietic stem cell transplantation outcomes: the physician's perspective
Mary Eapen, Vanderson Rocha
Hematology. American Society of Hematology. Education Program
|
January 18, 2011
Alternative donor transplantation for aplastic anemia
Mary Eapen, Mary M Horowitz
Page
of 21
Search research articles
Search
Showing results (11-20 of 208) with videos related to
Sort By:
Page
of 21
Hematology (Amsterdam, Netherlands)
|
April 18, 2012
Allogeneic transplantation for aplastic anemia
Mary Eapen
Best Practice & Research. Clinical Haematology
|
November 21, 2017
Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant?
Mary Eapen
Blood
|
January 5, 2023
To treat with curative intent or modify disease?
Mary Eapen
Haematologica
|
July 1, 2024
Immunosuppression with post-transplant cyclophosphamide for allogeneic hematopoietic cell transplantation
Mary Eapen
The Lancet. Haematology
|
February 3, 2019
In-vivo T-cell depletion: burden of morbidity versus survival
Mary Eapen
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 11, 2010
Bone marrow or peripheral blood
Mary Eapen
Best Practice & Research. Clinical Haematology
|
December 3, 2014
Unrelated donor transplantation: peripheral blood or bone marrow--does it matter?
Mary Eapen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 12, 2023
Reply to R. Meisel
Mary Eapen, Ruta Brazaukas
Lifetime Data Analysis
|
July 9, 2008
Principles and analysis of hematopoietic stem cell transplantation outcomes: the physician's perspective
Mary Eapen, Vanderson Rocha
Hematology. American Society of Hematology. Education Program
|
January 18, 2011
Alternative donor transplantation for aplastic anemia
Mary Eapen, Mary M Horowitz
Page
of 21